Members of the multidisciplinary team for head and neck cancer (formerly Appendix E)

The multidisciplinary team may include the following members: care coordinator (as determined by multidisciplinary team members)* medical oncologist / neuro-oncologist* neuropathologist* neuroradiologist* neurosurgeon* nurse (with appropriate expertise)* radiation oncologist* social worker* Aboriginal health practitioner, Indigenous liaison officer or remote general practitioner clinical trials coordinator dietitian exercise physiologist fertility specialist general practitioner geneticist neurologist neuropsychologist nuclear…

Read More

Expert working group (this edition)

Professor Mark Rosenthal (Chair), Medical Oncologist, The Royal Melbourne Hospital and Peter MacCallum Cancer Centre Professor Kate Drummond, Neurosurgeon, The Royal Melbourne Hospital, Peter MacCallum Cancer Centre and The University of Melbourne Professor Hui Gan, Medical Oncologist, Austin Health Associate Professor Alexander Holmes Consultant Psychiatrist, The Royal Melbourne Hospital and The University of Melbourne Professor…

Read More

Optimal Care Pathways Steering Committee

Alfred Health Cancer Australia Cancer Council Victoria, Strategy and Support Division Cancer Institute New South Wales Concord Repatriation General Hospital New South Wales Consumer representative Department of Health Victoria, Commissioning and System Improvement Division, Cancer Unit Olivia Newton-John Cancer Wellness and Research Centre St Vincent’s Hospital Melbourne Other stakeholders consulted to provide feedback including Integrated…

Read More

6.5 Advance care planning

Advance care planning is important for all patients with a cancer diagnosis but especially those with advanced disease. Patients should be encouraged to think and talk about their healthcare values and preferences with family or carers, appoint a substitute decision-maker and consider developing an advance care directive to convey their preferences for future health care…

Read More

6.1 Signs and symptoms of recurrent disease

Recurrent or progressive disease is very common for patients with high-grade glioma. For some patients the initial treatment will not control the tumour(s). Others may present with symptoms of recurrent disease after a previous cancer diagnosis. Access to the best available therapies, including clinical trials, as well as treatment overseen by a multidisciplinary team, are…

Read More

7.1 Multidisciplinary palliative care

If the treatment team does not include a palliative care member, the lead clinician should consider referring the patient to palliative care services, with the general practitioner’s engagement. This may include inpatient palliative unit access (as required). The multidisciplinary team may consider seeking additional expertise from these professionals: clinical psychologist clinical nurse specialist or practitioner…

Read More

5.3 Research and clinical trials

Support cancer survivors to participate in research or clinical trials where they are available and appropriate. These might include studies to understand survivors’ issues, to better manage treatment side effects, or to improve models of care and quality of life. For more information visit the COGNO website and the Cancer Australia website.

Read More